Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials

Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech

(2015) Hiroko Dodge et al.   Current Alzheimer Research

Novel Methods and Technologies for 21st-Century Clinical Trials

(2015) E. Ray Dorsey et al.   JAMA Neurology

Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease

(2014) Hiroko H. Dodge et al.   Alzheimers & Dementia

Associations Between Observed In-Home Behaviors and Self-Reported Low Mood in Community-Dwelling Older Adults

(2014) Stephen M. Thielke et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The A4 Study: Stopping AD Before Symptoms Begin?

(2014) R. A. Sperling et al.   Science Translational Medicine

Unobtrusive In-Home Detection of Time Spent Out-of-Home With Applications to Loneliness and Physical Activity

(2014) Johanna Petersen et al.   IEEE Journal of Biomedical and Health Informatics

The Preclinical Alzheimer Cognitive Composite

(2014) Michael C. Donohue et al.   JAMA Neurology

Sleep Habits in Mild Cognitive Impairment

(2013) Tamara L. Hayes et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: Conceptual framework and example

(2013) Jeannie-Marie S. Leoutsakos et al.   Alzheimers & Dementia

Unobtrusive measurement of daily computer use to detect mild cognitive impairment

(2013) Jeffrey Kaye et al.   Alzheimers & Dementia

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial

(2013) S.M. Mills et al.   REVUE NEUROLOGIQUE

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative

(2012) Joshua D. Grill et al.   NEUROBIOLOGY OF AGING

In-home walking speeds and variability trajectories associated with mild cognitive impairment

(2012) H. H. Dodge et al.   NEUROLOGY

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Intelligent Systems for Assessing Aging Changes: Home-Based, Unobtrusive, and Continuous Assessment of Aging

(2011) J. A. Kaye et al.   JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES

Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials

(2010) Lon S. Schneider et al.   Alzheimers & Dementia

The Trajectory of Gait Speed Preceding Mild Cognitive Impairment

(2010) Teresa Buracchio et al.   ARCHIVES OF NEUROLOGY

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

(2010) Christopher C. Rowe et al.   NEUROBIOLOGY OF AGING

Report of the task force on designing clinical trials in early (predementia) AD

(2010) P. S. Aisen et al.   NEUROLOGY

Unobtrusive and Ubiquitous In-Home Monitoring: A Methodology for Continuous Assessment of Gait Velocity in Elders

(2009) S. Hagler et al.   IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING

Unobtrusive assessment of activity patterns associated with mild cognitive impairment

(2008) Tamara L. Hayes et al.   Alzheimers & Dementia

Gait Dysfunction in Mild Cognitive Impairment Syndromes

(2008) Joe Verghese et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY